Back to search resultsSummaryRMgm-207
|
||||||||
*RMgm-207| Successful modification | The parasite was generated by the genetic modification |
| The mutant contains the following genetic modification(s) | Gene disruption |
| Reference (PubMed-PMID number) |
Reference 1 (PMID number) : 19220746 |
| MR4 number | |
| top of page | |
| Parent parasite used to introduce the genetic modification | |
| Rodent Malaria Parasite | P. berghei |
| Parent strain/line | P. berghei ANKA |
| Name parent line/clone | Not applicable |
| Other information parent line | |
| top of page | |
| The mutant parasite was generated by | |
| Name PI/Researcher | M. Yuda, I. Kaneko |
| Name Group/Department | Department of Medical Zoology |
| Name Institute | Mie University School of Medicine |
| City | Mie |
| Country | Japan |
| top of page | |
| Name of the mutant parasite | |
| RMgm number | RMgm-207 |
| Principal name | AP2-O (-) |
| Alternative name | |
| Standardized name | |
| Is the mutant parasite cloned after genetic modification | Yes |
| top of page | |
| Phenotype | |
| Asexual blood stage | Not different from wild type |
| Gametocyte/Gamete | Not different from wild type |
| Fertilization and ookinete | The mutant parasites formed morphologically normal female and male gametocytes and exhibited normal exflagellation rates. However, they lacked the ability to infect mosquitoes as no oocysts or sporozoites were found in the mosquito. In culture, mutant parasites formed zygotes at normal conversion rates and differentiated into retort forms by 9 h after fertilization, as in wild type parasites. Subtle morphological differences between wild type and mutant parasites became visible 12 h after fertilization with a swelling protrusion in the retort forms. Mature ookinetes showed an aberrant morphology with an pear-shaped form, different from the banana (sword)-like form of wild type ookinetes. |
| Oocyst | No oocyst and sporozoite production |
| Sporozoite | No oocyst and sporozoite production |
| Liver stage | Not tested |
| Additional remarks phenotype | Mutant/mutation Micro-array analysis of mutant retort-form ookinetes at 12h after fertilization showed decreased levels of transcripts of ookinete specific proteins. Evidence is presented that AP2-O binds to a six base sequence (TAGCTA) in the upstream promoter region of the genes whose transcripts are decreased in the absence of AP2-O. Evidence is presented that the TAGCTA sequence is a cis-acting element in the ookinete stage. |
Disrupted: Mutant parasite with a disrupted gene| top of page | |||||||||||||||||||||||||
| Details of the target gene | |||||||||||||||||||||||||
| Gene Model of Rodent Parasite | PBANKA_0905900 | ||||||||||||||||||||||||
| Gene Model P. falciparum ortholog | PF3D7_1143100 | ||||||||||||||||||||||||
| Gene product | AP2 domain transcription factor AP2-O, putative | ||||||||||||||||||||||||
| Gene product: Alternative name | AP2-O, AP2 in ookinetes; ApiAP2 | ||||||||||||||||||||||||
| top of page | |||||||||||||||||||||||||
| Details of the genetic modification | |||||||||||||||||||||||||
| Inducable system used | No | ||||||||||||||||||||||||
| Additional remarks inducable system | |||||||||||||||||||||||||
| Type of plasmid/construct used | Plasmid double cross-over | ||||||||||||||||||||||||
| PlasmoGEM (Sanger) construct/vector used | No | ||||||||||||||||||||||||
| Modified PlasmoGEM construct/vector used | No | ||||||||||||||||||||||||
| Plasmid/construct map | |||||||||||||||||||||||||
| Plasmid/construct sequence | |||||||||||||||||||||||||
| Restriction sites to linearize plasmid | |||||||||||||||||||||||||
| Partial or complete disruption of the gene | Partial | ||||||||||||||||||||||||
| Additional remarks partial/complete disruption | The hdhfr selectable marker gene was integrated into the AP2-O locus, replacing a relative small part of the coding sequence | ||||||||||||||||||||||||
| Selectable marker used to select the mutant parasite | hdhfr | ||||||||||||||||||||||||
| Promoter of the selectable marker | pbdhfr | ||||||||||||||||||||||||
| Selection (positive) procedure | pyrimethamine | ||||||||||||||||||||||||
| Selection (negative) procedure | No | ||||||||||||||||||||||||
| Additional remarks genetic modification | Two fragments of the AP2-O gene were amplified by PCR. The fragments were annealed to either side of the selectable marker gene (human DHFR) by PCR with primers 1 and 4. | ||||||||||||||||||||||||
| Additional remarks selection procedure | |||||||||||||||||||||||||
|
Primer information: Primers used for amplification of the target sequences
![]() Primer information: Primers used for amplification of the target sequences
| |||||||||||||||||||||||||
| top of page | |||||||||||||||||||||||||